Review ArticleHybrid Coronary Revascularization A ReviewNarasimhan, Seshasayee MD, MRCP, FRACP*; Srinivas, Vankeepuram S. MD*; DeRose, Joseph John Jr. MD† Author Information From the *Division of Cardiology, Montefiore-Einstein Heart Center, Bronx, NY; and †Department of Cardiovascular and Thoracic Surgery, Montefiore-Einstein Heart Center, Bronx, NY. Correspondence: Seshasayee Narasimhan, MD, MRCP (UK), FRACP, Department of Medicine, Cardiovascular Division, Jack D. Weiler Hospital of the Albert Einstein College of Medicine, 1825 Eastchester Rd, Bronx, NY 10461–2373. E-mail: [email protected]. Cardiology in Review: May 2011 - Volume 19 - Issue 3 - p 101-107 doi: 10.1097/CRD.0b013e3182140330 Buy Metrics Abstract The long-term benefits of a left internal mammary artery bypass graft compared to the left anterior descending artery have been well described. The use of drug-eluting stents has minimized the morbidity of revascularization. Hybrid coronary revascularization is the planned use of minimally invasive surgical techniques for left internal mammary artery-left anterior descending artery grafting and the use of percutaneous coronary intervention for nonleft anterior descending coronary artery target revascularization. The optimal timing and order of revascularization in hybrid coronary revascularization remains unclear. © 2011 Lippincott Williams & Wilkins, Inc.